Patents by Inventor Yuka TABUCHI

Yuka TABUCHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220412962
    Abstract: Disclosed is a detection method for detecting occurrence of nonspecific reaction in analysis for an antigen or an antibody contained in a biological sample with use of a measurement reagent containing an antibody or an antigen that causes antigen-antibody reaction with the antigen or the antibody in the biological sample, and the detection method includes: generating a data group about progress of antigen-antibody reaction between the antigen or the antibody contained in the biological sample and the antibody or the antigen contained in the measurement reagent; inputting the data group to a deep learning algorithm; and generating information about occurrence of nonspecific reaction, based on a result outputted by the deep learning algorithm.
    Type: Application
    Filed: March 31, 2022
    Publication date: December 29, 2022
    Applicant: SYSMEX CORPORATION
    Inventors: Yuka TABUCHI, Konobu KIMURA, Keisuke NISHI, Osamu KUMANO, Takeshi SUZUKI
  • Publication number: 20220115091
    Abstract: Disclosed is an analysis method for a blood specimen, including: obtaining a data group including a plurality of data forming a blood coagulation curve or a differential curve thereof; inputting the data group into a deep learning algorithm; and outputting, on the basis of a result obtained from the deep learning algorithm, information regarding a cause of prolongation of blood coagulation time of the blood specimen.
    Type: Application
    Filed: October 8, 2021
    Publication date: April 14, 2022
    Applicant: SYSMEX CORPORATION
    Inventors: Yuka TABUCHI, Konobu KIMURA, Keisuke NISHI, Osamu KUMANO
  • Patent number: 10215766
    Abstract: Disclosed is a blood sample determination method including: emitting light to a measurement specimen prepared by mixing a clotting time measuring reagent and a blood sample suspected to be derived from a subject having lupus anticoagulant or a coagulation factor inhibitor, to obtain optical information about an amount of light from the measurement specimen; obtaining at least one parameter regarding derivative of clot waveform, based on the obtained optical information; and determining, based on a value of the obtained parameter, whether the blood sample is suspected to be a sample derived from a subject having lupus anticoagulant or is suspected to be a sample derived from a subject having a coagulation factor inhibitor.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: February 26, 2019
    Assignees: PUBLIC UNIVERSITY CORPORATION NARA MEDICAL UNIVERSITY, SYSMEX CORPORATION
    Inventors: Midori Shima, Keiji Nogami, Yuka Tabuchi, Hiroshi Kurono
  • Publication number: 20180031539
    Abstract: Disclosed is a method for determining the severity of hemophilia, the method including the steps of: coagulating a blood specimen to acquire a coagulation waveform; acquiring an average change rate of a coagulation rate from the coagulation waveform; and determining the severity of hemophilia in the blood specimen based on the average change rate of the coagulation rate.
    Type: Application
    Filed: July 27, 2017
    Publication date: February 1, 2018
    Applicants: SYSMEX CORPORATION, PUBLIC UNIVERSITY CORPORATION NARA MEDICAL UNIVERSITY
    Inventors: Midori SHIMA, Keiji NOGAMI, Tomoko MATSUMOTO, Yuka TABUCHI, Nobuo ARAI
  • Publication number: 20160178651
    Abstract: Disclosed is a blood sample determination method including: emitting light to a measurement specimen prepared by mixing a clotting time measuring reagent and a blood sample suspected to be derived from a subject having lupus anticoagulant or a coagulation factor inhibitor, to obtain optical information about an amount of light from the measurement specimen; obtaining at least one parameter regarding derivative of clot waveform, based on the obtained optical information; and determining, based on a value of the obtained parameter, whether the blood sample is suspected to be a sample derived from a subject having lupus anticoagulant or is suspected to be a sample derived from a subject having a coagulation factor inhibitor.
    Type: Application
    Filed: December 15, 2015
    Publication date: June 23, 2016
    Applicants: PUBLIC UNIVERSITY CORPORATION NARA MEDICAL UNIVERSITY, SYSMEX CORPORATION
    Inventors: Midori SHIMA, Keiji NOGAMI, Yuka TABUCHI, Hiroshi KURONO